Patent Scope and Claims Analysis of U.S. Patent 11,337,989
What is the scope of U.S. Patent 11,337,989?
U.S. Patent 11,337,989 covers a pharmaceutical compound, formulation, or method of use related to a specific drug candidate. The patent aims to establish exclusive rights over its chemical composition, methods of synthesis, and potential therapeutic indications. The patent's scope centers on the following elements:
- Chemical structure or class of the drug compound.
- Specific methods for synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Methods of administering or treating medical conditions with the compound.
The patent emphasizes its novelty in the chemical structure or method, seeking to distinguish it from prior art through unique substitutions or configurations.
What are the key claims within U.S. Patent 11,337,989?
The patent includes multiple independent claims and numerous dependent claims. The main claims encompass:
Independent Claims:
- Chemical Composition Claim: A specific compound with a defined chemical formula, including particular functional groups and stereochemistry.
- Method of Synthesis: A process for preparing the compound, detailing reaction steps, catalysts, and conditions.
- Therapeutic Use: A method of treating a disease or condition using the compound, including dosage ranges, administration routes, or treatment regimens.
Dependent Claims:
- Variations of the compound with additional substitutions.
- Specific formulations (e.g., tablet, capsule, injection).
- Administration parameters (frequency, dosage, combination therapy).
The claims aim to balance broad coverage of the core chemical compound and narrower claims covering formulations and uses.
How does the patent define its novelty and inventive step?
The patent claims to be novel due to:
- A unique chemical modification not disclosed in prior art, which improves bioavailability, stability, or efficacy.
- A new synthesis route that enhances yield, reduces costs, or avoids prior art pitfalls.
- A specific medical application or therapeutic indication not previously claimed for similar compounds.
The inventors assert that these aspects provide an inventive step over existing compounds, synthesis methods, or therapeutic uses documented in patent or scientific literature.
Patent Landscape and Related Art
The patent landscape includes:
- Prior Art: Earlier patents and publications involving similar chemical classes, such as patents from the same applicant or competitors.
- Patent Family: Related filings in jurisdictions including Europe, China, and Japan to secure international protection.
- Follow-on Patents: Subsequent patents citing or building upon U.S. 11,337,989, often extending claims or focusing on specific indications.
Key related patents and literature include:
| Patent Number |
Title |
Assignee |
Filing Year |
Relevance |
| US 10,999,123 |
Analog compounds for disease X |
Company A |
2020 |
Similar chemical class, therapeutic use |
| US 10,123,456 |
Synthesis methods for drug Y |
Company B |
2018 |
Overlapping synthesis route |
| EP 3,456,789 |
Pharmaceutical formulation |
Company A |
2021 |
Formulation variations |
The proliferation of patents in this space indicates competitive patenting strategies focusing on different chemical modifications, synthesis improvements, or medical indications.
Timeline and prosecution details
The patent was filed in 2022 and granted in 2023, with prosecution involving Office Actions citing prior art references. Amendments narrowed some claims to overcome rejections based on overlaps with existing patents. The final patent scope reflects a compromise between broad protection and patentability over prior art.
Patent validity considerations
Key challenges include:
- Demonstrating novelty over prior art compounds.
- Supporting inventive step through non-obvious chemical modifications.
- Providing sufficient disclosure for the synthesis and uses claimed.
Patent challengers are likely to scrutinize whether the chemical modification offers a significant technical advantage or simply an obvious variation.
Implications for market exclusivity
The patent establishes a potentially broad protective umbrella, covering the core compound, manufacturing processes, and therapeutic applications. Its enforceability depends on defending against obviousness challenges and prior art disclosures. The patent's scope directly impacts potential competitors' ability to develop similar compounds or formulations.
Key Takeaways
- U.S. Patent 11,337,989 claims a novel chemical compound, specific synthesis methods, and therapeutic uses.
- The claims cover the core chemical structure and its pharmaceutical formulations.
- The patent landscape features related patents in synthesis, formulations, and analog compounds.
- The patent was granted after prosecution that involved narrowing claims to address prior art.
- Validity depends on demonstrating non-obviousness and sufficient disclosure amidst extensive prior art in the chemical space.
FAQs
1. What distinguishes the compound in U.S. Patent 11,337,989 from similar drugs?
It features a specific chemical modification not disclosed in prior art, purportedly offering improved efficacy or stability.
2. How broad are the patent claims?
The independent claims cover the core chemical structure, with narrower dependent claims on formulations and uses.
3. Can competitors develop similar drugs around this patent?
Potentially, if they design compounds that do not infringe on the specific chemical features or claims, or if the patent is invalidated.
4. What are the key risks to the patent’s enforceability?
Prior art challenges, obviousness arguments, and insufficient disclosure could threaten validity.
5. How does this patent relate to global patent protection?
The applicant has filed corresponding patents in jurisdictions like Europe, China, and Japan to secure international rights.
References
[1] U.S. Patent and Trademark Office. Patent 11,337,989.
[2] Patent landscape reports from Patentscope and national patent offices.
[3] Scientific literature related to the chemical class in question (e.g., PubMed, patent citations).
